IGN-2098

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIGN-2098
Drug Alias NameIGN-2098
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H2 receptor antagonists
TargetsHistamine H2 receptor
Therapy Area/IndicationsDuodenal Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAska Pharmaceutical Co LtdIkeda Mohando Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIkeda Mohando Co LtdAska Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsDuodenal Ulcer

Other Information

ATC CodeN/A
Related LinksN/A